Thermo to Buy Qiagen for $10 Billion in 2020’s Top Health Deal
U.S. laboratory equipment maker Thermo Fisher Scientific Inc. agreed to buy Qiagen NV, a Dutch maker of tests for diseases including cancer and the new coronavirus, for about 9 billion euros ($10 billion) in the biggest health-care acquisition so far this year.
News story posted on 2020-03-03T11:30:00.0000000Z
